Results 51 to 60 of about 11,143 (189)
Improved estimation of left ventricular volume from electric field modeling
Volume measurement is beneficial in left ventricular assist device (LVAD) therapy to quantify patient demand. In principle, an LVAD could provide a platform that allows bioimpedance measurements inside the ventricle without requiring additional implants.
Korn Leonie +3 more
doaj +1 more source
Displays bar graphs showing outcome rates stratified by clinical and hemodynamic variables. Asterisks (*) denote statistically significant differences (p ≤ 0.05). “NS” indicates non‐significant comparisons. Percentages are shown above each bar. The top panel corresponds to acute kidney injury (blue bars), and the bottom panel corresponds to acute ...
Tess Calcagno +23 more
wiley +1 more source
Recent Developments in Ventricular Assist Device Therapy
The evolution of left ventricular assist devices (LVADs) from large, pulsatile systems to compact, continuous-flow pumps has significantly improved implantation outcomes and patient mobility. Minimally invasive surgical techniques have emerged that offer
Angel Moctezuma-Ramirez +3 more
doaj +1 more source
Background The incidence and impact of noise in a subcutaneous implantable cardioverter defibrillator (S‐ICD) after left ventricular assist device (LVAD) implantation is not well established.
Banveet Kaur Khetarpal +7 more
doaj +1 more source
Impacts of Hemodynamic Support on Ventricular Arrhythmia Ablation
ABSTRACT Background Data on the efficacy of hemodynamic support (HS) for protecting ventricular arrhythmia (VA) ablation in high‐risk heart failure (HF) patients with an impaired left ventricular function and its impact on mortality is limited. Objectives This study aimed to assess procedural efficacy, related complications, VA‐free survival, and ...
Denise Guckel +12 more
wiley +1 more source
Aim. To study mortality, postoperative complications, clinical course, and quality of life of patients with heart failure (HF) within 6 months after left ventricular assist device (LVAD) implantation.Material and methods.
Zh. A. Shakhramanova +10 more
doaj +1 more source
ABSTRACT Background In patients with structural heart disease (SHD) and moderately impaired left ventricular ejection fraction (LVEF > 35%), data on outcomes after ventricular tachycardia (VT) ablation remain limited. This analysis focuses on VT recurrence after ablation in patients presenting with sustained VT and LVEF > 35% within a secondary ...
Said‐Elias Waezsasa +14 more
wiley +1 more source
In 15 postoperative cardiac surgery patients, venous reactive oxygen species (ROS) measured by electron spin resonance (ESR) over 48 h showed no consistent circadian pattern. Higher ROS was associated with lower subjective sleep efficiency and more nocturnal awakenings, but not with other sleep measures.
K. Krawczyk +10 more
wiley +1 more source
Impact of ICD Presence in Patients With Left Ventricular Assist Devices for End‐Stage Heart Failure
ABSTRACT Background The prognostic relevance of implantable cardioverter defibrillator (ICD) in patients with end‐stage heart failure (HF) with left ventricular assist device (LVAD) remains controversial. Objectives To evaluate the prognostic impact of ongoing use of ICD and associated complications in HF‐patients with LVAD‐implantation.
Nafilah Baridwan +11 more
wiley +1 more source
Abstract figure legend The capillary–mitochondria–ion channel (CMIC) axis scales structural resources to match functional workload. (Left) In settings of restricted energetic capacity (e.g. cortical neurons), sparse capillary networks and modest mitochondrial pools set a lower energetic ceiling, sufficient to support phasic, low‐workload excitability. (
L. Fernando Santana, Scott Earley
wiley +1 more source

